Study to Assess the Safety/Pharmacokinetics of Recomb Interleukin 21 (rIL-21) Admined Concomitantly w/Sorafenib (Nexavar) in Subjects w/Metastatic Renal Cell Carcinoma
|Effective start/end date||7/1/07 → 12/31/11|
- ZYMOGENITICS INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.